Yalcinkaya Kalyan,E.Can Celik,S.Okan,O.Akdeniz,G.Karabulut,S.Caliskan,E.2024-05-252024-05-2520190303-456910.1111/and.134032-s2.0-85070923880https://doi.org/10.1111/and.13403https://hdl.handle.net/20.500.14517/2443The most recent technologies for sperm sorting involve microfluidics. However, the most important question whether their use is of any advantage in terms of laboratory and clinical IVF/ICSI outcomes still remains controversy. In this study, we aimed to investigate whether a microfluidic sperm sorting device (Fertile Plus®) has a positive add-on effect on laboratory and clinical outcomes. Sibling oocytes of 81 patients were assigned to two sperm sorting groups including swim up and Fertile Plus®. All embryos were cultured until day 5/6. Fertilisation, embryo quality and blastocyst development were assessed as primary outcomes among 81 patients; clinical pregnancy, implantation and live birth rates were analysed as secondary outcomes as a subgroup analysis due to transfer cancellations. No statistically significant differences were found between groups in terms of all outcomes analysed in laboratory and clinical terms (p >.05 for all). The results of this study suggest that sorting spermatozoa through Fertile chip does not improve laboratory outcomes significantly and does not seem to have a positive contribution to clinical outcomes. © 2019 Blackwell Verlag GmbHeninfo:eu-repo/semantics/openAccesschipimplantationintracytoplasmic sperm injectionmicrofluidicsiblingArticleQ2Q25110PubMed:3143416515